EssilorLuxottica S.A. (USD) EssilorLuxottica S.A., established in Paris, France, in 1849, is a prominent global entity in the optical industry. The company specializes in the creation, production, and worldwide distribution of a diverse range of vision products, including ophthalmic lenses, eyewear frames, and sunglasses, catering to markets across North America, Europe, Latin America, Asia, Oceania, and Africa. Its extensive operations are divided into five key segments: Wholesale, Retail, Lenses and Optical Instruments, Equipment, and Sunglasses and Readers. The Wholesale division is responsible for manufacturing and supplying premium and athletic eyewear to other businesses. Conversely, the Retail segment directly offers luxury and sports eyewear to consumers through its various sales channels. The Lenses and Optical Instruments segment provides a broad spectrum of lenses, such as Varilux progressive lenses, Crizal anti-reflective and anti-smudge coatings, Transitions photochromic lenses (including the Gen 8 series), Eyezen lenses optimized for digital screen use, and Xperio polarized sun lenses, alongside corrective options from Nikon and Kodak. This segment also furnishes optical instruments, including lens edging and mounting equipment for opticians and laboratories, and optometry tools for a variety of professionals and institutions, while also developing online optical sales solutions. The Equipment segment focuses on delivering advanced digital surfacing and lens coating machinery to prescription laboratories, integrated optical chains, and lens manufacturers. Lastly, the Sunglasses and Readers segment encompasses a wide array of non-prescription sunglasses and reading glasses, available under numerous well-known proprietary brands like Foster Grant, Magnivision, and SolarShield, licensed brands such as Reebok, Steve Madden, and Disney, and regional labels including Bolon and Mujosh. To support its expansive business, EssilorLuxottica maintains a substantial network of 490 prescription laboratories and edging-mounting facilities globally. The company formally adopted the name EssilorLuxottica Société anonyme in October 2018, having previously been known as Essilor International Société Anonyme.

EssilorLuxottica S.A. (USD) Active

1-5 rue Paul CEzanne, Paris, FR, 75008

Stock Price USD

Price Change

Last Dividend USD

Latest Rating

ESLOY's stock peer is CSLLY (CSL Limited)

ESLOY's stock peer is FSNUY (Fresenius SE & Co. KGaA)

ESLOY's stock peer is HOCPF (HOYA Corporation)

ESLOY's stock peer is HOCPY (HOYA Corporation)

ESLOY's stock peer is MECNY (Menicon Co Ltd)

ESLOY's stock peer is NONOF (Novo Nordisk A/S)

ESLOY's stock peer is SMMNY (Siemens Healthineers AG)

ESLOY's stock peer is SOAGY (Sartorius Aktiengesellschaft)

ESLOY's stock peer is SRTOY (Sartorius Stedim Biotech S.A.)

Healthcare Medical - Instruments & Supplies

EssilorLuxottica S.A., established in Paris, France, in 1849, is a prominent global entity in the optical industry. The company specializes in the creation, production, and worldwide distribution of a diverse range of vision products, including ophthalmic lenses, eyewear frames, and sunglasses, catering to markets across North America, Europe, Latin America, Asia, Oceania, and Africa. Its extensive operations are divided into five key segments: Wholesale, Retail, Lenses and Optical Instruments, Equipment, and Sunglasses and Readers. The Wholesale division is responsible for manufacturing and supplying premium and athletic eyewear to other businesses. Conversely, the Retail segment directly offers luxury and sports eyewear to consumers through its various sales channels. The Lenses and Optical Instruments segment provides a broad spectrum of lenses, such as Varilux progressive lenses, Crizal anti-reflective and anti-smudge coatings, Transitions photochromic lenses (including the Gen 8 series), Eyezen lenses optimized for digital screen use, and Xperio polarized sun lenses, alongside corrective options from Nikon and Kodak. This segment also furnishes optical instruments, including lens edging and mounting equipment for opticians and laboratories, and optometry tools for a variety of professionals and institutions, while also developing online optical sales solutions. The Equipment segment focuses on delivering advanced digital surfacing and lens coating machinery to prescription laboratories, integrated optical chains, and lens manufacturers. Lastly, the Sunglasses and Readers segment encompasses a wide array of non-prescription sunglasses and reading glasses, available under numerous well-known proprietary brands like Foster Grant, Magnivision, and SolarShield, licensed brands such as Reebok, Steve Madden, and Disney, and regional labels including Bolon and Mujosh. To support its expansive business, EssilorLuxottica maintains a substantial network of 490 prescription laboratories and edging-mounting facilities globally. The company formally adopted the name EssilorLuxottica Société anonyme in October 2018, having previously been known as Essilor International Société Anonyme.

80%

Dcf Rating

60%

Return On Equity

80%

Return On Assets

40%

Debt To Equity

20%

Price To Earnings

40%

Price To Book

Income Statement

Dividend Stats Yield is calculated via trailing-12-month period

Ex-Dividend	Payment Date	Dividend	Yield	Dividend Frequency
2026-05-11	2026-06-23	2.32	2.35 %	Annual
2025-05-12	2025-06-26	2.25	1.62 %	Annual
2024-05-06	2024-06-18	2.11	1.97 %	Annual
2023-05-23	2023-06-28	1.77	1.82 %	Annual
2022-05-31	2022-07-06	1.32	1.64 %	Annual
2021-06-07	2021-07-06	0.64	1.53 %	Semi-Annual
2019-05-28	2019-06-13	1.14	1.90 %	Annual
2018-04-25	2018-05-15	0.94	1.38 %	Annual
2017-05-16	2017-06-08	0.84	1.29 %	Semi-Annual
	2016-06-29	0.63	0.97 %	Annual
	2015-06-11	0.55	0.89 %	Annual
	2014-06-17	0.65	1.22 %	Annual
	2013-06-25	0.57	1.01 %	Annual
	2012-06-19	0.57	1.29 %	Annual
	2011-06-09	0.59	1.50 %	Annual
		0.48	1.69 %	Annual
		0.45	1.94 %	Annual
		0.48	1.54 %	Annual

Recent News

EssilorLuxottica and Meta expand the accessibility of wearables category with new collection

EssilorLuxottica and Meta expand the accessibility of wearables category with new collection Building on their market-leading portfolio of AI glasses, the two companies aim to introduce more consumers to smart eyewear innovation Paris, France and Menlo Park, CA (23 June 2026) – EssilorLuxottica and Meta announced the launch of Meta Glasses, a new collection of AI glasses aimed at opening up the smart eyewear category to broader audiences, including consumers looking for more attainable innovation. The two companies have established the AI glasses category from the ground up with the deepest lineup of products ranging from Ray-Ban Meta, the #1 selling AI glasses in the world, to Oakley Meta, ushering in a new era of Athletic Intelligence, to Meta Ray-Ban Display, the first of its kind with an in-lens display.

2026-06-23 09:07:00

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of May 31, 2026

Disclosure of Share Capital and Voting Rights Outstanding as of May 31, 2026 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers) Paris, France (June 9, 2026 - 6:00 pm) – As of May 31, 2026, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks down as indicated below. May 31, 2026 Shares outstanding 463,289,594 Number of real voting rights (excluding treasury shares) 459,253,760 Theoretical number of voting rights (including treasury shares) 463,289,594 It is to be noted that voting rights are capped at 31%, applicable to any shareholder, in accordance with a formula contained in article 23 of EssilorLuxottica's by-laws1.

2026-06-09 12:00:00

EssilorLuxottica: Result of the payment of dividends in shares and record of the corresponding capital increase

Result of the payment of dividends in shares and record of the corresponding capital increase Paris, France (June 1, 2026) – The Annual General Meeting of EssilorLuxottica has decided to grant to the shareholders the option to receive their dividend in shares. The price for newly issued shares for the payment of the dividend has been set at Euro 175.06 per share.

2026-06-01 10:30:00

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2026

Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2026 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers) Paris, France (May 12, 2026 - 6:00 pm) – As of April 30, 2026, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks down as indicated below. April 30, 2026 Shares outstanding 463,289,594 Number of real voting rights (excluding treasury shares) 459,253,760 Theoretical number of voting rights (including treasury shares) 463,289,594 It is to be noted that voting rights are capped at 31%, applicable to any shareholder, in accordance with a formula contained in article 23 of EssilorLuxottica's by-laws1.

2026-05-12 12:00:00

EssilorLuxottica: First-Quarter 2026 Revenue Conference Call Invitation

First-Quarter 2026 Revenue Conference Call Invitation Mr STEFANO GRASSI, Chief Financial Officer, andMr GIORGIO IANNELLA, Head of Investor Relations,have the pleasure of inviting you to our First-Quarter 2026 Revenue Conference Call on: Wednesday, April 22, 2026, at 6:30 pm CEST Dial-in telephone access: If you wish to dial into the conference call, please pre-register at the following link to receive the personal credentials (Dial-in numbers, Conference ID and User ID): https://grid.trustwavetechnology.com/essilorluxottica/register.html If you encounter any issue in the pre-registration phase you may contact ir@essilorluxottica.com, providing your name and surname and the name of your company. Live webcast: You can watch the presentation at the following link: https://streamstudio.world-television.com/1217-2090-43269/en The press release will be published at 6:00 pm CEST on the same day and the presentation slides will be made available prior to the call.

2026-04-10 12:00:00

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of March 31, 2026

Disclosure of Share Capital and Voting Rights Outstanding as of March 31, 2026 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers) Paris, France (April 10, 2026 - 6:00 pm) – As of March 31, 2026, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks down as indicated below. March 31, 2026 Shares outstanding 463,289,594 Number of real voting rights (excluding treasury shares) 460,461,309 Theoretical number of voting rights (including treasury shares) 463,289,594 It is to be noted that voting rights are capped at 31%, applicable to any shareholder, in accordance with a formula contained in article 23 of EssilorLuxottica's by-laws1.

2026-04-10 12:00:00

EssilorLuxottica acquires a stake in Top Charoen, reinforcing its presence in Thailand

EssilorLuxottica acquires a stake in Top Charoen, reinforcing its presence in Thailand Paris, France and Bangkok, Thailand (2 April 2026) – EssilorLuxottica and Top Charoen today announced that they have closed a transaction for EssilorLuxottica to become the partner of Top Charoen through the acquisition of a meaningful stake, cementing the long-standing relationship between the two companies. Top Charoen is Thailand's largest retail chain with over 2,000 stores across all regions of the country.

2026-04-02 12:00:00

Disclaimers

StockQuay.com is not operated by a broker, dealer, or registered investment advisor. Under no circumstances should any information published on StockQuay.com be considered a recommendation to buy, sell, or hold any security. The content on this site and in its associated newsletters is intended solely for informational and educational purposes and does not constitute investment advice or financial recommendations.

Individuals or entities featured or referenced on StockQuay.com may engage in trading activity involving the securities mentioned in any article or report before or after such content is published. These individuals or entities are not affiliated with StockQuay.com, and their inclusion does not imply endorsement or accuracy of their views or actions.

StockQuay.com, its owners, or its affiliates shall not be held liable to any user or third party for any damages or losses arising from the use of content on this website. This includes, but is not limited to, investment losses, loss of profit, loss of data, missed opportunities, or indirect, incidental, or consequential damages.

Data is updated daily and is not guaranteed to be accurate or complete.

Past performance is not indicative of future results. Please conduct your own research or consult with a qualified financial advisor before making any investment decisions